Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
---|---|---|---|---|---|---|---|---|---|
TPST | Tempest Therapeutics, Inc. | Common Stock, par value $0.001 per share | 4.8% | $174K | 2.12M | Versant Vantage II, L.P. | Nov 12, 2024 |
Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Date Filed |
---|